PureLife, TOPICAL ANESTHETIC GEL, BENZOCAINE 20%, 1 oz (30mL)
Recalled by Keystone Industries
Class II — moderate
Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Keystone Industries has recalled PureLife, TOPICAL ANESTHETIC GEL, BENZOCAINE 20%, 1 oz (30mL), according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on June 24, 2026 and was initiated on May 21, 2026. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers PureLife, TOPICAL ANESTHETIC GEL, BENZOCAINE 20%, 1 oz (30mL), with approximately 450 units affected. The company behind the recall is Keystone Industries, based in Gibbstown, NJ. The FDA describes the product as: “PureLife, TOPICAL ANESTHETIC GEL, BENZOCAINE 20%, 1 oz (30mL), Strawberry Flavor, Manufactured for Pure Life, LLC, Manufactured for PureLife LLC., Carson, CA 90810. NDC 68987-001-30”
Why was PureLife, TOPICAL ANESTHETIC GEL, BENZOCAINE 20%, 1 oz (30mL) recalled?
According to the FDA, the stated reason for the recall is: “Defective container:may contain bottles with incomplete seals.”
What should you do?
If you think you may have bought PureLife, TOPICAL ANESTHETIC GEL, BENZOCAINE 20%, 1 oz (30mL), compare it against the product description and identifying codes (BNZ-001921, EXP 04/15/2029) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Keystone Industries or your local health authority.
About this recall
This recall was distributed in NJ. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- June 24, 2026
- Recall started
- May 21, 2026
- Distributed in
- NJ
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was PureLife, TOPICAL ANESTHETIC GEL, BENZOCAINE 20%, 1 oz (30mL) recalled?+
According to the FDA: Defective container:may contain bottles with incomplete seals
How serious is this recall?+
Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
What should I do if I have PureLife, TOPICAL ANESTHETIC GEL, BENZOCAINE 20%, 1 oz (30mL)?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0605-2026. Information last synced from the FDA on July 6, 2026.